Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

March 11, 2003; 60 (5) Articles

Risk factors for fever in the neurologic intensive care unit

Christopher Commichau, Nikolaos Scarmeas, Stephan A. Mayer
First published March 11, 2003, DOI: https://doi.org/10.1212/01.WNL.0000047344.28843.EB
Christopher Commichau
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikolaos Scarmeas
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan A. Mayer
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Risk factors for fever in the neurologic intensive care unit
Christopher Commichau, Nikolaos Scarmeas, Stephan A. Mayer
Neurology Mar 2003, 60 (5) 837-841; DOI: 10.1212/01.WNL.0000047344.28843.EB

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1459

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Objective: To identify risk factors for fever among patients treated in a neurologic intensive care unit (NICU).

Methods: The authors prospectively studied the frequency and causes of fever, defined as a patient’s first temperature ≥101 °F (38.3 °C), among 387 patients consecutively admitted to their NICU. After identifying risk factors for 1) any fever, 2) infectious fever, and 3) unexplained fever using logistic regression, they calculated disease-specific adjusted odds ratios for developing these types of fever among 12 diagnostic groups.

Results: Fever occurred in 23% (87/387) of patients. Fifty-two percent of fevers were explained by infection (predominantly pneumonia or bronchitis), and 28% were unexplained despite a complete diagnostic evaluation. NICU length of stay was a risk factor for all three types of fever (all p < 0.004); other risk factors included depressed level of consciousness for any fever (p = 0.005) and infectious fever (p = 0.048), endotracheal intubation for infectious fever (p = 0.01), and intraventricular catheterization for unexplained fever (p = 0.004). Subarachnoid hemorrhage increased the risk of both infectious and unexplained fever, even after adjusting for these risk factors (p = 0.006).

Conclusion: Fever occurs in nearly 25% of NICU patients, and is associated with increased length of stay and depressed level of consciousness. Endotracheal intubation is a risk factor for infectious fever, whereas intraventricular catheterization is a risk factor for unexplained fever, which suggests a role for ventricular hemorrhage in the pathogenesis of “central” fever. Subarachnoid hemorrhage increases the risk of developing fever of all types.

The adverse effect of temperature elevation on neurologic recovery in acutely brain-injured patients has become increasingly recognized in recent years. Even when delayed, 1 to 2 degrees of hyperthermia has deleterious effects on outcome in experimental models of focal and global ischemia and traumatic brain injury (TBI).1-3⇓⇓ The risk of poor functional outcome is increased with even mild temperature elevation (>37.5 °C) on admission after ischemic stroke4,5⇓ or intracerebral hemorrhage (ICH),6 and sustained high fevers are associated with poor outcome after aneurysmal subarachnoid hemorrhage (SAH).7 Brain temperature elevations have also been associated with elevated intracranial pressure after SAH and TBI.8

Given the potentially harmful effects of hyperthermia in neurocritical care patients, there is increasing interest in the application of devices and pharmacologic interventions that might prevent fever.9-13⇓⇓⇓⇓ Among patients with acute brain injury, it would be useful to identify those at high risk for fever, in order to target suitable candidates for prophylactic thermomodulatory therapy. One retrospective study of fever in neurologic intensive care unit (NICU) patients found an overall frequency of 47% and associations with increased ICU length of stay and cranial (as opposed to spinal) disease.14 We studied the frequency of fever in NICU patients and examined clinical and disease-specific risk factors for its occurrence.

Methods.

Patient population.

We prospectively screened all patients admitted to the Columbia-Presbyterian Medical Center NICU between February 11, 1999 and June 20, 1999 throughout their ICU stay for the presence of fever, defined as any temperature ≥38.3 °C (101 °F).15 As per existing NICU practice, temperature was recorded hourly in all patients using an infrared tympanic thermometer (Genius 3000A, Sherwood Medical, St. Louis, MO). Patients with fever were identified daily by reviewing each patient’s maximal temperature recorded during each 12-hour shift in the nursing charge report. The study protocol was approved by the Columbia-Presbyterian Institutional Review Board. Because of the observational nature of this study and lack of significant risk to patients, the need for written informed consent was waived.

Patient-level variables.

The following variables were recorded for all patients admitted to the NICU during this period at the time of ICU discharge: demographic variables—age, sex, race/ethnicity; clinical variables—fever (present/absent), ICU length of stay (LOS), craniotomy (yes/no), level of consciousness (alert/depressed), limb weakness (present/absent); procedures and instruments (all present/absent)—craniotomy, bladder catheter, arterial catheter, central venous catheter, pulmonary artery catheter, endotracheal tube, intraventricular catheter (IVC).

At the time of ICU discharge, patients were assigned by a single investigator (C.C.) to one of 12 principal diagnostic categories, based on a review of radiology reports and clinical data: ICH, SAH, cerebral infarction, TBI, CNS neoplasm, seizures, respiratory failure, unruptured aneurysm, carotid endarterectomy, interventional neuroradiology (INR) procedure, medical complication, and other neurosurgical procedure. Vital status at hospital discharge was classified as dead or alive.

Diagnostic evaluation of fever.

For each patient who developed a fever, all of the following diagnostic studies obtained within 48 hours of fever onset were recorded: chest radiography (CXR), blood cultures, sputum cultures, urine cultures, and CSF cultures. Blood cultures were obtained separately from a peripheral source and a central venous catheter, when present. Additionally, the results of all Clostridiumdifficile toxin assays and lower extremity Doppler studies obtained in the NICU were reviewed (all patients are routinely screened for deep vein thrombosis between 7 and 14 days in our NICU). These test results and the medical record were reviewed independently by two investigators (C.C. and N.S.), each of whom assigned a diagnostic category for fever according to the following criteria15: explained, infectious—pneumonia (purulent sputum with positive culture, with infiltrate on CXR), bronchitis (purulent sputum with positive culture, without infiltrate on CXR), sinusitis (positive nasal culture, with sinus opacification on CT), urinary tract infection (pyuria with positive urine culture of >100 K colonies), bloodstream infection (two positive blood cultures associated with local IV catheter site inflammation or the systemic inflammatory response syndrome [hyperthermia/hypothermia, tachycardia, tachypnea, and leukocytosis/leukopenia]16), cellulitis (warmth and blanching erythema), C. difficile enteritis (positive toxin assay), meningitis/ventriculitis (polymorphonuclear pleocytosis with positive CSF culture); explained, noninfectious—deep vein thrombosis (positive lower extremity Doppler), atelectasis (characteristic findings in two or more lung segments on CXR), drug fever (resolution of fever after drug discontinuation); unexplained (none of the above criteria identified); or incomplete diagnostic evaluation (lack of CXR or blood, urine, or sputum culture). When the two independent reviewers disagreed initially on the final diagnostic category, the data were re-examined until a consensus was reached.

Statistical analysis.

Differences in proportions were compared using Pearson χ2 test, and normally distributed continuous variables were compared using Student two-tailed t-test. After identifying demographic, clinical, and procedure/instrumentation variables associated with fever in a univariate analysis, significant independent predictors of fever were identified by entering all candidate variables identified in the univariate analysis (p < 0.05) into a backward stepwise logistic regression model, using p < 0.05 as the criterion for final retention in the model. To determine whether specific diagnoses predispose to fever, we calculated unadjusted and adjusted odds ratios (OR) for developing any fever, infectious fever, and unexplained fever within each diagnostic category. Adjusted OR were calculated by evaluating the partial coefficient for each diagnostic category after being added individually to the models of any, infectious, and unexplained fever that we developed previously. Assuming a two-sided χ2 test and a significance level of 0.05, a minimum of 25 patients within any diagnostic category would yield 80% power to detect an unadjusted OR for fever of 2.5 or greater.

Results.

Study population.

Over the 18-week study period, 387 patients were admitted to the NICU. Mean age was 54.1 ± 17.6 years (range 17 to 98). There were 208 men and 178 women studied. Mean NICU LOS was 3.3 ± 5.1 days (range 0 to 38). The number and proportion of patients assigned to each of the 12 diagnostic categories is shown in table 1. Of the 33 patients assigned to the other neurosurgical procedure group, the most common procedures included spinal laminectomy or fusion (n = 9), extracranial-intracranial bypass (n = 4), and encephaloduroangiosynostosis (n = 4). Of the 17 patients assigned to the medical complication group, the most common diagnoses were toxic metabolic encephalopathy (n = 5) and hypoxic-ischemic encephalopathy (n = 4).

View this table:
  • View inline
  • View popup

Table 1 Risk of developing fever (T ≥38.3 °C) by diagnostic category

Fever of any cause.

Eighty-seven patients (23%) developed fever, defined as at least one recorded temperature ≥38.3 °C. Pneumonia or bronchitis was by far the most common cause of infectious fever, accounting for 42% of cases overall (table 2). The second most common category was unexplained fever (28%). Nineteen percent of patients had no source of fever identified, but did not have a complete diagnostic evaluation.

View this table:
  • View inline
  • View popup

Table 2 Causes of fever

Seven variables were associated with fever in the univariate analysis (all p < 0.0001): longer ICU LOS; non-alert level of consciousness; limb weakness; placement of a central venous, arterial, or ventricular catheter; and endotracheal intubation (table 3). After entering these seven candidate variables into a stepwise backward logistic regression model, ICU LOS (OR 1.30 per day in ICU, 95% CI 1.19 to 1.41, p < 0.0001) and depressed level of consciousness (OR 2.36, 95% CI 1.30 to 4.31, p = 0.005) were identified as significant independent risk factors for fever.

View this table:
  • View inline
  • View popup

Table 3 Univariate analysis of risk factors for fever among neuro-ICU patients

Table 1 shows the proportion of patients within each category with fever, and for each diagnostic group, the adjusted OR for developing fever after correcting for ICU LOS and level of consciousness. SAH was the only diagnostic group associated with any fever after adjusting for level of consciousness and ICU LOS; 65% of patients with SAH were febrile overall, with an uncorrected OR of 8.1 (p < 0.001) and a corrected OR of 3.36 (p = 0.006). Patients with TBI also were at increased risk for developing fever, with an overall frequency of 40% and an unadjusted OR of 2.46 (p = 0.03), but the adjusted OR for this association did not reach significance. With the exception of patients who underwent craniotomy for clipping of an unruptured aneurysm or resection of neoplasm, patients admitted to the ICU for monitoring after neurosurgical or INR procedures were at low risk for developing fever.

Infectious fever.

Forty-five patients (12%) were classified as having infectious fever. In a univariate analysis comparing patients with and without infectious fever, the same seven variables that were associated with fever of any cause (see table 3) were also associated with fever of infectious cause (all p < 0.0004, data not shown). In addition, craniotomy was associated with an increased risk of infectious fever (p = 0.01, χ2 test). After entering these eight candidate variables into a backward stepwise logistic regression model, ICU length of stay (OR 1.14, 95% CI 1.07 to 1.21 per day in ICU, p < 0.0001), endotracheal intubation (OR 3.33, 95% CI 1.33 to 8.33, p = 0.01), and depressed level of consciousness (OR 2.40, 95% CI 1.01 to 5.71, p = 0.048) were identified as independent risk factors for infectious fever. SAH was the only diagnostic category independently associated with infectious fever after accounting for these risk factors (adjusted OR 2.96, p = 0.02, see table 1).

Unexplained fever.

Twenty-six patients (7%) were classified as having unexplained (or possibly central) fever. In a univariate analysis comparing patients with and without unexplained fever, the same seven variables that were associated with fever of any cause were also associated with unexplained fever (see table 3, all p < 0.01, data not shown). After entering these seven candidate variables into a backward stepwise logistic regression model, ICU length of stay (OR 1.7, 95% CI 1.02 to 1.13 per day in ICU, p < 0.004) and the presence of an IVC (OR 4.63, 95% CI 1.62 to 13.21, p = 0.004) were identified as independent risk factors for unexplained fever. Of the 27 IVCs placed, 88% were placed in SAH (n = 10) or ICH patients (n = 14) with intaventricular hemorrhage (IVH), whereas 12% (n = 3) were placed in patients with CNS neoplasms. SAH was the only diagnostic category independently associated with unexplained fever after accounting for other risk factors (adjusted OR 2.76, p = 0.046, see table 1).

Mortality.

Hospital mortality was 9.2% (8/87) among patients with fever, compared to 4.1% (12/295) among those without (p = 0.09).

Discussion.

We studied the frequency, causes, and predictors of fever in 387 consecutively admitted NICU patients. Fever defined as any temperature ≥38.3 °C occurred in 23% of subjects. In slightly over half the fever was associated with an infection, and in approximately one quarter no cause could be identified, suggesting central fever. ICU LOS and depressed level of consciousness increased the risk of fever in general, endotracheal intubation predicted infectious fever (which was most often related to lung infection), and IVC placement was associated with unexplained fever. SAH increased the risk of both infectious and unexplained fever, even after adjusting for these risk factors, which may reflect hypothalamic dysfunction and abnormal thermo-regulation in these patients.

The frequency of fever in our neurocritical care population (23%) is similar to that among hospitalized patients in general (29%),17 but lower than has been reported in neurosurgical ICU patients (47%),14 which may reflect differences in patient acuity: we treated substantially fewer TBI patients than the aforementioned study, and had more patients who underwent uncomplicated neurosurgical or endovascular procedures. According to admission diagnosis, the highest rate of fever in our study occurred in patients with SAH (65%), followed by TBI (40%) and ICH (31%). A higher frequency of fever (approximately 70%) was reported within 3 days of admission for SAH and TBI in a small retrospective study of randomly selected ICU patients,18 and among general medical-surgical ICU patients.19

We identified non-alert level of consciousness and increased ICU LOS as independent risk factors for developing fever from any cause. Depressed level of consciousness may predispose to fever because of impaired thermoregulation related to brain injury, or from complications resulting from prolonged immobilization, such as atelectasis, pneumonia, and urinary tract infection. Increased ICU LOS has previously been associated with fever in neurosurgical and general medical-surgical ICU patients14,19⇓; however, it remains unclear whether fever per se is a cause or effect of increased ICU LOS. We did not calculate admission Acute Physiology and Chronic Health Evaluation II scores, a global measure of disease severity and mortality risk for ICU patients, which are predictive of fever in medical-surgical ICU patients.19

Fever was associated with infection in 50% of our subjects (see table 2), which is nearly identical to the proportion of fevers attributed to infection in medical-surgical ICU patients (53%).19 Pulmonary infections (bronchitis and pneumonia) accounted for 82% of infections in our study, and are the predominant cause of infectious fever in patients with stroke,20,21⇓ whereas a more diverse spectrum of infections occur in hospitalized or critically ill medical-surgical patients with fever.17,19⇓ Coma is a well-established risk factor for nosocomial pneumonia in neurosurgical ICU patients.22,23⇓ In addition to depressed level of consciousness and ICU LOS, we also identified endotracheal intubation as an independent risk factor for infectious fever, which probably reflects the additional risk of ventilator-associated pneumonia in these patients.24 Noninfectious processes such as deep vein thrombosis and atelectasis were infrequently associated with fever in our population, in accordance with studies challenging the notion that these conditions often generate a febrile response.25,26⇓

No cause of fever was identified despite a complete diagnostic evaluation in 28% of our patients, suggesting fever of central origin. Although regularly encountered and routinely diagnosed by exclusion in clinical practice, very little empiric research regarding central fever has been performed to date, which may relate in part to difficulty in establishing the diagnosis with certainty. Refractory high fever (>42 °C) in the immediate aftermath of massive supratentorial or brainstem ICH is well described, and is the basic observation supporting central fever as a clinical entity.27-29⇓⇓ In 330 hospitalized patients with stroke, unexplained fever occurred in 15%, and was associated with earlier onset than infection-related fever; no other predictors were identified.20 In our NICU patient population, increased ICU LOS and IVC placement (which was usually performed for IVH) were associated with unexplained fever. Although fever in general has been associated with IVH in ICH patients6 and IVC placement after SAH,7 to our knowledge the association between IVC placement and unexplained fever that we found is the first clinical observation to corroborate animal experiments demonstrating hyperthermia after intraventricular blood or albumin injection,30,31⇓ and to support the notion that IVH can cause central fever in humans. The mechanism by which IVH may alter hypothalamic function and cause central fever is speculative: direct hemotoxic damage to thermoregulatory centers in the preoptic region, interference with tonic inhibitory inputs from the lower midbrain that ordinarily suppress thermogenesis, and stimulation of prostaglandin production leading to temperature set-point elevation have all been invoked.32

We found that patients with SAH have enhanced susceptibility to both infectious and unexplained fever, even after controlling for the risk factors that we identified (see table 1). Of note, patients with TBI appeared to have increased susceptibility to infectious fever, but this association failed to reach significance (see table 1). The association of fever with SAH is well described, and its development 4 to 6 days after onset has been correlated with the development of cerebral vasospasm.33 Our data suggest that patients with SAH may have a generalized disturbance of thermoregulation, which might result from either hypothalamic dysfunction and set-point elevation related to the frequent presence of thick clot in the suprasellar cistern or impaired heat-dissipating mechanisms resulting from intense activation of the sympathetic nervous system and generalized peripheral vasoconstriction.34 In this view, whether the initial pyrogenic stimulus is infectious or central in origin, body temperature may tend to run higher in SAH than in other neurocritical care patients.

Several weaknesses of our study deserve mention. For the sake of simplicity, we only analyzed first fever in the NICU, so many patients initially classified as having infectious fever may have had unexplained fevers later on, and vice versa. We used tympanic thermometers, which may be unreliable in critically ill patients35,36⇓; although this does not limit the internal validity of our study, it may limit its applicability to patients with core temperature measurements. We did not record many clinical details, such as the day of onset and duration of fever, maximum body temperature, or response to treatment. We also did not systematically evaluate brain CT scans in order to evaluate radiographic predictors of fever. Some of the diagnostic categories we analyzed were represented in small numbers, resulting in inadequate statistical power to detect associations between these conditions and fever. Finally, because this study was strictly observational, meaning that the evaluation of fever was ultimately left to the discretion of the attending physician, 19% of our febrile patients lacked a complete diagnostic evaluation as we defined it. Hence, we have probably underestimated the proportion of febrile NICU patients who have infectious or unexplained fever.

Our findings may have implications for clinical practice. Mortality was more than twice as high in febrile than in nonfebrile patients (9.2 vs 4.1%). Although not significant, this trend supports previous observations that fever is associated with poor outcome after acute brain injury.4-7⇓⇓⇓ Our results suggest that the risk of fever in mechanically ventilated and comatose acute stroke and neurotrauma patients is sufficiently high to warrant early active intervention to maintain normothermia and prevent fever. A similar management strategy might also be reasonable for noncomatose SAH and IVC-treated ICH patients. Clinical trials are needed to determine whether interventions of this type are feasible, safe, and effective in terms of improving outcome.

Acknowledgments

Acknowledgment

The authors thank Y. Evelyn Du, PhD, for statistical advice, and Mary Prescutti, RN, for coordinating the nursing protocols involved in this study.

  • Received May 17, 2002.
  • Accepted October 28, 2002.

References

  1. ↵
    Baena RC, Busto R, Dietrich WD, Globus MY, Ginsberg MD. Hyperthermia delayed by 24 hours aggravates neuronal damage in rat hippocampus following global ischemia. Neurology . 1997; 48: 768–773.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Kim Y, Busto R, Dietrich WD, Kraydich S, Ginsberg MD. Delayed postischemic hyperthermia in awake rats worsens the histopathologic outcome of transient forebrain ischemia. Stroke . 1996; 27: 2274–2281.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Dietrich WD, Alonso O, Halley M, Busto R. Delayed posttraumatic brain hyperthermia worsens outcome after fluid percussion brain injury: a light and electron microscopic study in rats. Neurosurgery . 1996; 38: 533–541.
    OpenUrlCrossRefPubMed
  4. ↵
    Hajat C, Hajat S, Sharma P. Effects of post-stroke pyrexia on stroke outcome. A meta-analysis of studies on patients. Stroke . 2000; 31: 410–414.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Wang Y, Lim L L-Y, Levi C, Heller RF, Fisher J, Maths B. Influence of admission body temperature on stroke mortality. Stroke . 2000; 31: 404–409.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Schwarz S, Häfner K, Aschoff A, Schwab S. Incidence and prognostic of fever following intracerebral hemorrhage. Neurology . 2000; 54: 354–361.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology . 2001; 56: 1299–1304.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Rossi S, Roncati Zanier E, Mauri I, Columbo A, Stocchetti N. Brain temperature, body core temperature, and intracranial pressure in acute cerebral damage. J Neurol Neurosurg Psychiatry . 2001; 71: 448–454.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke . 1998; 29: 529–534.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Mayer SA, Commichau C, Scarmeas N, Presciutti M, Bates J, Copeland D. Clinical trial of an air-circulating cooling blanket for fever control in critically ill neurologic patients. Neurology . 2001; 56: 292–298.
    OpenUrlFREE Full Text
  11. ↵
    Mayer SA, Kowalski RG, Ostapkovitch N, Fitzsimmons B-F, Yavagal DY. Normalization of body temperature in febrile neuro-ICU patients with the Arctic Sun Temperature Management System. Neurology . 2002; 58 (suppl 3): A93.Abstract.
    OpenUrl
  12. ↵
    Dippel DWJ, van Breda EJ, van Gemert HMA, et al. Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: a double-blind, randomized phase II clinical trial. Stroke . 2001; 32: 1607–1612.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Kasner SE, Wein T, Piriyawat P, et al. Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. Stroke . 2002; 33: 130–135.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Kilpatrick MM, Lowry DW, Firlik AD, Yonas H, Marion DW. Hyperthermia in the neurosurgical intensive care unit. Neurosurgery . 2000; 47: 850–856.
    OpenUrlCrossRefPubMed
  15. ↵
    O’Grady NP, Barie PS, Bartlett J, et al. Practice parameters for evaluating new fever in critically ill adult patients. Crit Care Med . 1998; 26: 392–408.
    OpenUrlCrossRefPubMed
  16. ↵
    Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med . 1992; 20: 864–874.
    OpenUrlCrossRefPubMed
  17. ↵
    McGowan JE, Rose RC, Jacobs NF, Schaberg DR, Haley RW. Fever in hospitalized patients. With special reference to the medical service. Am J Med . 1987; 82: 580–586.
    OpenUrlCrossRefPubMed
  18. ↵
    Albrecht RF, Wass CT, Lanier WL. Occurrence of potentially detrimental temperature alterations in hospitalized patients at risk for brain injury. Mayo Clin Proc . 1998; 73: 629–635.
    OpenUrlCrossRefPubMed
  19. ↵
    Circiumaru B, Baldock G, Cohen J. A prospective study of fever in the intensive care unit. Int Care Med . 1999; 25: 668–673.
    OpenUrlCrossRefPubMed
  20. ↵
    Georgilis K, Plomaritoglou A, Dafni U, Bassiakos Y, Vemmos K. Aetiology of fever in patients with acute stroke. J Int Med . 1999; 246: 203–209.
    OpenUrlCrossRefPubMed
  21. ↵
    Przelomski MM, Roth RM, Gleckman RA, Marcus EM. Fever in the wake of stroke. Neurology . 1986; 36: 427–429.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Rello J, Ausina V, Ricart M, et al. Nosocomial pneumonia in critically ill comatose patients: need for a differential therapeutic approach. Eur Respir J . 1992; 5: 1249–1253.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Tay L, Ong PL, Lang L. Nosocomial infections in a neurosurgery department. Ann Acad Med Singapore . 1987; 16: 565–570.
    OpenUrlPubMed
  24. ↵
    Sofianou DC, Constandinidis TC, Yannacou M, Anastasiou H, Sofianos E. Analysis of risk factors for ventilator-associated pneumonia in a multidisciplinary intensive care unit. Eur J Clin Micro Infect Dis . 2000; 19: 460–463.
    OpenUrlCrossRefPubMed
  25. ↵
    Kazmers A, Groehn H, Meeker C. Do patients with acute deep vein thrombosis have fever? Am Surgeon . 2000; 66: 598–601.
    OpenUrlPubMed
  26. ↵
    Roberts J, Barnes W, Pennock M, Browne G. Diagnostic accuracy of fever as a measure of postoperative pulmonary complications. Heart Lung . 1988; 17: 166–169.
    OpenUrlPubMed
  27. ↵
    Chin RL. High temperature with cerebral hemorrhage. Ann Emerg Med . 1999; 34: 411.Letter.
    OpenUrl
  28. ↵
    Kitanaka C, Inoh Y, Toyoda T, Sasaki T, Eguchi T. Malignant brain stem hyperthermia caused by brain stem hemorrhage. Stroke . 1994; 25: 518–520.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Erickson TC. Neurogenic hyperthermia (a clinical syndrome and its treatment). Brain . 1939; 62: 172–190.
    OpenUrlFREE Full Text
  30. ↵
    Morimoto A, Murakami N, Nakamori T, Watanabe T. Fever induced in rabbits by intraventricular injection of rabbit and human serum albumin. J Physiol (Lond) . 1987; 390: 137–144.
    OpenUrlPubMed
  31. ↵
    Rudy TA, Westergaard JL, Yaksh TL. Hyperthermia produced by simulated intraventricular hemorrhage in the cat. Exp Neurol . 1978; 58: 296–310.
    OpenUrlPubMed
  32. ↵
    Shibata M. Hyperthermia in brain hemorrhage. Med Hypoth . 1998; 50: 185–190.
    OpenUrlCrossRefPubMed
  33. ↵
    Rousseaux P, Scherpereel B, Bernard MH, Graftieaux JP, Guyot JF. Fever and cerebral vasospasm in ruptured intracranial aneurysms. Surg Neurol . 1980; 14: 459–465.
    OpenUrlPubMed
  34. ↵
    Mayer SA, Lin J, Homma N, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke . 1999; 30: 780–786.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Fulbrook P. Core body temperature measurement: a comparison of axilla, tympanic membrane, and pulmonary artery blood temperature. Intensive Crit Care Nurs . 1997; 13: 266–272.
    OpenUrlCrossRefPubMed
  36. ↵
    Giuliano KK, Giuliano AJ, Scott SS, et al. Temperature measurement in critically ill adults: a comparison of tympanic and oral methods. Am J Crit Care . 2000; 9: 254–261.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Association Between Fluctuations in Blood Lipid Levels Over Time With Incident Alzheimer Disease and Alzheimer Disease–Related Dementias

Dr. Sevil Yaşar and Dr. Behnam Sabayan

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Prognosis
  • Critical care

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Clinical trial of an air-circulating cooling blanket for fever control in critically ill neurologic patients
    S.A. Mayer, C. Commichau, N. Scarmeas et al.
    Neurology, February 13, 2001
  • Resident and Fellow Section
    Emerging Subspecialties in Neurology: Neurocritical care
    Asma Zakaria, J. Javier Provencio, George A. Lopez et al.
    Neurology, April 28, 2008
  • Article
    Neuro R2 score
    Predicting high-risk neurologic readmissions within 30 days
    Sarah H. Peacock, Ami A. Grek, Emily R. Rogers et al.
    Neurology, March 13, 2020
  • Articles
    Withdrawal of life support in the neurological intensive care unit
    Stephan A. Mayer, Sharon B. Kossoff et al.
    Neurology, May 01, 1999
Neurology: 101 (13)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise